ESPR icon

Esperion Therapeutics

148 hedge funds and large institutions have $426M invested in Esperion Therapeutics in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$22.5M
Puts
$4.14M
Net Calls
Net Calls Change

Top Buyers

1 +$11.6M
2 +$7.18M
3 +$5.25M
4
SSA
Schonfeld Strategic Advisors
New York
+$4.98M
5
Two Sigma Investments
Two Sigma Investments
New York
+$4.6M

Top Sellers

1 -$6.59M
2 -$3.37M
3 -$3.21M
4
DTC
Deep Track Capital
Connecticut
-$2.43M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.36M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$95K
102
$88K
103
$87K
104
$87K
105
$87K
106
$85K
107
$80K
108
$73K
109
$71K
110
$68K
111
$68K
112
$68K
113
$68K
114
$65K
115
$55K
116
$51K
117
$47K
118
$42K
119
$36K
120
$31K
121
$30K
122
$27K
123
$22K
124
$17K
125
$13K